Table 3.
USA | EU | China | Algeria | ||
---|---|---|---|---|---|
Regulatory agency | Food and Drug Administration (FDA) |
|
|
NA | |
Regulation and law |
|
|
|
/ | |
Compliance process |
|
Notification/registration |
|
/ | |
Category | Foods | + | + | + | + |
Medicines | − | − | − | − | |
Manufacturer Registration | − | + (Limited) |
+ | − | |
Presence of a positive list | − | + | + | NA | |
Good Manufacturing Practice (GMP) | + | + (HACCP) |
+ | NA | |
Clinical trials of individual products | − | + (New ingredients) |
+ (New ingredients) |
NA | |
Obligated to display the usage and dosage | + | + | + | NA | |
Serious adverse event reporting | + | + | − | NA | |
Labeling and packaging | + | + | + | NA | |
Shape description | + | + | Often | NA | |
Advertising requirements | + | + | + | NA | |
Health claims | − | − | − | NA |
+/−: presence/absence of the factor; NA: not annotated.